Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial LesionsMark Haas, Michael Mengel, B. Sis et al.|American Journal of Transplantation|2014Cited by 1.3k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trialsMark Haas, Michael Mengel, Alexandre Loupy et al.|American Journal of Transplantation|2017Cited by 1k
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft SurvivalAlexandre Loupy, Xavier Jouven|New England Journal of Medicine|2013Cited by 826
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejectionAlexandre Loupy, Michael Mengel, Mark Haas et al.|American Journal of Transplantation|2020Cited by 809
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular PathologyAlexandre Loupy, Michael Mengel, Mark Haas et al.|American Journal of Transplantation|2016Cited by 625